The potential of adipokines as biomarkers and therapeutic agents for vascular complications in type 2 diabetes mellitus.

Affiliation

Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Shanghai, 200025, China. Electronic address: [Email]

Abstract

Over the past decades, there has been a major increase in type 2 diabetes (T2D) prevalence in most regions of the world. Diabetic patients are more prone to cardiovascular complications. Accumulating evidence suggests that adipose tissue is not simply an energy storage tissue but it also functions as a secretory tissue producing a variety of bioactive substances, also referred to as adipokines. The balance between pro-inflammatory adipokines and protective adipokines is disturbed in type 2 diabetes, this can be regarded as adipose tissue dysfunction which partly promote the pathogenesis of diabetes complications. In this review, we not only discuss the favorable adipokines like adiponectin, omentin, C1q tumor necrosis factor-related proteins, but also unfavorable ones like resisitin and visfatin, in the aim of finding potential biomarkers recommended for the clinical use in the diagnosis, prognosis and follow up of patients with T2D at high risk of developing cardiovascular diseases as well as leading to new therapeutic approaches.

Keywords

Adipokines,Adipose tissue,Cardiovascular disease,Type 2 diabetes,Vascular endothelial dysfunction,

OUR Recent Articles